Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI

TL;DR

This paper introduces HGNN-DDI, a heterogeneous graph neural network that integrates multiple biomedical data sources to accurately predict drug-drug interactions, improving safety in drug development and personalized medicine.

Contribution

The paper presents a novel heterogeneous graph neural network model that effectively captures complex relationships in biomedical networks for DDI prediction.

Findings

HGNN-DDI outperforms existing methods in accuracy.

The model demonstrates robustness across datasets.

Effective integration of diverse biomedical data sources.

Abstract

Drug-drug interactions (DDIs) are a major concern in clinical practice, as they can lead to reduced therapeutic efficacy or severe adverse effects. Traditional computational approaches often struggle to capture the complex relationships among drugs, targets, and biological entities. In this work, we propose HGNN-DDI, a heterogeneous graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources. HGNN-DDI leverages graph representation learning to model heterogeneous biomedical networks, enabling effective information propagation across diverse node and edge types. Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness, highlighting its potential to support safer drug development and precision medicine.